I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
COVID-19
- Phase
- Phase 2
- Status
- Active Not Recruiting
- Enrollment
- 1,500 Estimated
- Expected completion
- Jul 31, 2030
- Record updated
- Mar 16, 2026
- Lead sponsor
- QuantumLeap Healthcare Collaborative